Top Page
Oxford Nanopore Technologies PLC
(LSE:ONT)
Oxford Nanopore Technologies PLC (ONT) vs. iShares MSCI United Kingdom ETF (EWC)
Oxford Nanopore Technologies PLC Business Overview & Revenue Model
Oxford Nanopore Technologies PLC Earnings Call Summary
Oxford Nanopore Technologies PLC Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 151.91M | 183.19M | 169.67M | 198.60M | 133.66M | 113.86M |
| Gross Profit | 86.63M | 105.39M | 90.48M | 123.81M | 73.19M | 46.88M |
| EBITDA | -101.49M | -93.09M | -105.71M | -49.67M | -140.34M | -55.07M |
| Net Income | -107.44M | -146.19M | -154.51M | -91.03M | -167.61M | -61.24M |
Balance Sheet | ||||||
| Total Assets | 671.70M | 742.05M | 777.06M | 823.89M | 841.87M | 281.21M |
| Cash, Cash Equivalents and Short-Term Investments | 331.80M | 338.37M | 270.05M | 476.19M | 618.47M | 80.86M |
| Total Debt | 44.10M | 45.96M | 41.66M | 34.10M | 24.80M | 23.63M |
| Total Liabilities | 148.30M | 155.71M | 133.21M | 130.33M | 137.89M | 95.28M |
| Stockholders Equity | 523.40M | 586.34M | 643.85M | 693.56M | 703.98M | 185.93M |
Cash Flow | ||||||
| Free Cash Flow | -84.45M | -123.83M | -164.59M | -91.62M | -84.64M | -90.28M |
| Operating Cash Flow | -74.11M | -109.89M | -137.30M | -49.39M | -53.83M | -63.81M |
| Investing Cash Flow | 50.76M | 15.03M | -61.79M | -65.79M | -161.99M | -26.94M |
| Financing Cash Flow | 72.15M | 73.58M | 64.73M | -13.71M | 622.90M | 158.58M |
Oxford Nanopore Technologies PLC Technical Analysis
Oxford Nanopore Technologies PLC Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
59 Neutral | £299.69M | 8.68 | 15.04% | ― | 1231.50% | ― | |
54 Neutral | £748.29M | ― | -74.64% | ― | 55.44% | 75.77% | |
53 Neutral | £305.57M | ― | ― | ― | ― | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | £1.32B | -9.02 | -26.01% | ― | 22.03% | 20.01% | |
46 Neutral | £102.22M | -7.46 | ― | ― | ― | -94.12% | |
39 Underperform | £121.56M | -7.90 | -209.34% | ― | 198.49% | -26.66% |
Oxford Nanopore Technologies PLC Corporate Events
Oxford Nanopore Technologies has announced an investor event on November 14, 2025, to discuss its commercial strategy and growth opportunities. Additionally, the company will participate in the J.P. Morgan UK Leaders Conference and the Jefferies Global Healthcare Conference in November, offering presentations and meetings with investors. These events aim to enhance investor understanding of the company’s market potential and strategic direction.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £2.40 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Oxford Nanopore Technologies PLC announced a transaction involving the Share Incentive Plan (SIP) where 100 ordinary shares were awarded to Nick Keher, the company’s Chief Financial Officer, as part of the SIP. This transaction, which took place on 14 October 2025, involved the purchase of shares using the employee’s gross salary and the issuance of matching shares by the company, reflecting its commitment to employee investment and engagement.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £2.40 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Oxford Nanopore Technologies PLC has announced the issuance of 630,273 ordinary shares following the exercise of options and remuneration schemes, which have been admitted to the FCA’s Official List and the London Stock Exchange. This increases the company’s total issued share capital to 963,779,781 shares, providing a new denominator for shareholders to calculate their interests under the FCA’s rules.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £2.40 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Oxford Nanopore Technologies PLC announced the issuance of Partnership Shares and Matching Shares under its Share Incentive Plan (SIP) for Nick Keher, the company’s Chief Financial Officer. The transaction involved the purchase of 89 ordinary shares at £1.69 each, matched by an equal number of shares issued by the company, reflecting its commitment to employee participation in ownership and aligning managerial interests with shareholder value.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £2.10 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
The recent earnings call of Oxford Nanopore Technologies PLC presented a balanced overview of the company’s current performance. The sentiment expressed during the call was positive regarding revenue growth and the data center segment’s performance, while also acknowledging declines in gaming revenue and challenges within the China market.
Oxford Nanopore Technologies reported strong financial performance for the first half of 2025, with revenue growth across all regions and customer segments, driven by increased demand in research and applied markets. The company made significant progress in strategic priorities, including product innovation and a new partnership with Cepheid for infectious disease solutions, while maintaining a strong balance sheet and refining their commercial strategy to target high-priority applications.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £250.00 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Oxford Nanopore Technologies PLC announced the issuance of 964,529 ordinary shares following the exercise of options and remuneration schemes, which have been admitted to the FCA’s Official List and the London Stock Exchange. This issuance increases the company’s total voting rights to 963,149,508, providing shareholders with a new denominator for interest calculations under FCA rules.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £250.00 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Oxford Nanopore Technologies PLC announced a transaction involving its Share Incentive Plan (SIP), where 73 ordinary shares were awarded to Nick Keher, the Chief Financial Officer, as part of a share purchase and matching scheme. This initiative is part of the company’s strategy to align managerial interests with shareholder value, potentially enhancing stakeholder confidence and reinforcing its market position.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £250.00 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Oxford Nanopore Technologies plc has announced that its CEO, Gordon Sanghera, will step down by the end of 2026 after over 20 years in the role. The company has initiated a formal search for a successor to continue its growth and commercialization efforts. Under Sanghera’s leadership, the company has become a global business with a highly differentiated technology platform, achieving sustained growth and a strong market position. The transition is part of a long-standing succession plan, and the board is focused on finding a leader to advance the company’s growth strategy and create long-term value for stakeholders.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £250.00 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Oxford Nanopore Technologies has announced the re-appointment of Deloitte LLP as its external auditor following a competitive tender process. This decision aligns with the company’s audit partner rotation schedule and is subject to shareholder approval at the 2026 Annual General Meeting. The re-appointment is expected to impact the company’s operations by ensuring continuity in auditing practices, which could influence stakeholder confidence and the company’s industry positioning.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £250.00 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Oxford Nanopore Technologies has initiated legal proceedings against MGI Australia Pty Ltd. for infringing on four of its Australian patents. This move underscores the company’s commitment to protecting its intellectual property, which is crucial for sustaining innovation and long-term value creation. The legal action highlights the importance of safeguarding proprietary technology to ensure continued investment and availability of high-performance solutions to customers and partners.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £250.00 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Oxford Nanopore Technologies PLC has announced the issuance of 1,119,988 ordinary shares following the exercise of options and remuneration schemes, which have been admitted to trading on the London Stock Exchange. This increases the company’s total issued share capital to 962,184,979 ordinary shares, impacting shareholder voting rights and potentially influencing market dynamics.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £250.00 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.